Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      CRTC2 activates the epithelial–mesenchymal transition of diabetic kidney disease through the CREB-Smad2/3 pathway

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Epithelial–mesenchymal transition (EMT) plays a key role in tubulointerstitial fibrosis, which is a hallmark of diabetic kidney disease (DKD). Our previous studies showed that CRTC2 can simultaneously regulate glucose metabolism and lipid metabolism. However, it is still unclear whether CRTC2 participates in the EMT process in DKD.

          Methods

          We used protein‒protein network (PPI) analysis to identify genes that were differentially expressed during DKD and EMT. Then, we constructed a diabetic mouse model by administering STZ plus a high-fat diet, and we used HK-2 cells that were verified to confirm the bioinformatics research results. The effects that were exerted by CRTC2 on epithelial-mesenchymal transition in diabetic kidney disease through the CREB-Smad2/3 signaling pathway were investigated in vivo and in vitro by real-time PCR, WB, IHC and double luciferase reporter gene experiments.

          Results

          First, bioinformatics research showed that CRTC2 may promote EMT in diabetic renal tubules through the CREB-Smad2/3 signaling pathway. Furthermore, the Western blotting and real-time PCR results showed that CRTC2 overexpression reduced the expression of E-cadherin in HK-2 cells. The CRTC2 and α-SMA levels were increased in STZ-treated mouse kidneys, and the E-cadherin level was reduced. The luciferase activity of α-SMA, which is the key protein in EMT, was sharply increased in response to the overexpression of CRTC2 and decreased after the silencing of CREB and Smad2/3. However, the expression of E-cadherin showed the opposite trends. In the real-time PCR experiment, the mRNA expression of α-SMA increased significantly when CRTC2 was overexpressed but partially decreased when CREB and Smad2/3 were silenced. However, E-cadherin expression showed the opposite result.

          Conclusion

          This study demonstrated that CRTC2 activates the EMT process via the CREB-Smad2/3 signaling pathway in diabetic renal tubules.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s10020-023-00744-0.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.

          R. Edgar (2002)
          The Gene Expression Omnibus (GEO) project was initiated in response to the growing demand for a public repository for high-throughput gene expression data. GEO provides a flexible and open design that facilitates submission, storage and retrieval of heterogeneous data sets from high-throughput gene expression and genomic hybridization experiments. GEO is not intended to replace in house gene expression databases that benefit from coherent data sets, and which are constructed to facilitate a particular analytic method, but rather complement these by acting as a tertiary, central data distribution hub. The three central data entities of GEO are platforms, samples and series, and were designed with gene expression and genomic hybridization experiments in mind. A platform is, essentially, a list of probes that define what set of molecules may be detected. A sample describes the set of molecules that are being probed and references a single platform used to generate its molecular abundance data. A series organizes samples into the meaningful data sets which make up an experiment. The GEO repository is publicly accessible through the World Wide Web at http://www.ncbi.nlm.nih.gov/geo.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            STRING v10: protein–protein interaction networks, integrated over the tree of life

            The many functional partnerships and interactions that occur between proteins are at the core of cellular processing and their systematic characterization helps to provide context in molecular systems biology. However, known and predicted interactions are scattered over multiple resources, and the available data exhibit notable differences in terms of quality and completeness. The STRING database (http://string-db.org) aims to provide a critical assessment and integration of protein–protein interactions, including direct (physical) as well as indirect (functional) associations. The new version 10.0 of STRING covers more than 2000 organisms, which has necessitated novel, scalable algorithms for transferring interaction information between organisms. For this purpose, we have introduced hierarchical and self-consistent orthology annotations for all interacting proteins, grouping the proteins into families at various levels of phylogenetic resolution. Further improvements in version 10.0 include a completely redesigned prediction pipeline for inferring protein–protein associations from co-expression data, an API interface for the R computing environment and improved statistical analysis for enrichment tests in user-provided networks.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Diabetic kidney disease

              The kidney is arguably the most important target of microvascular damage in diabetes. A substantial proportion of individuals with diabetes will develop kidney disease owing to their disease and/or other co-morbidity, including hypertension and ageing-related nephron loss. The presence and severity of chronic kidney disease (CKD) identify individuals who are at increased risk of adverse health outcomes and premature mortality. Consequently, preventing and managing CKD in patients with diabetes is now a key aim of their overall management. Intensive management of patients with diabetes includes controlling blood glucose levels and blood pressure as well as blockade of the renin-angiotensin-aldosterone system; these approaches will reduce the incidence of diabetic kidney disease and slow its progression. Indeed, the major decline in the incidence of diabetic kidney disease (DKD) over the past 30 years and improved patient prognosis are largely attributable to improved diabetes care. However, there remains an unmet need for innovative treatment strategies to prevent, arrest, treat and reverse DKD. In this Primer, we summarize what is now known about the molecular pathogenesis of CKD in patients with diabetes and the key pathways and targets implicated in its progression. In addition, we discuss the current evidence for the prevention and management of DKD as well as the many controversies. Finally, we explore the opportunities to develop new interventions through urgently needed investment in dedicated and focused research. For an illustrated summary of this Primer, visit: http://go.nature.com/NKHDzg.
                Bookmark

                Author and article information

                Contributors
                liyujie.11@163.com
                wangvenbo@126.com
                tongxiaolin@vip.163.com
                Journal
                Mol Med
                Mol Med
                Molecular Medicine
                BioMed Central (London )
                1076-1551
                1528-3658
                26 October 2023
                26 October 2023
                2023
                : 29
                : 146
                Affiliations
                [1 ]GRID grid.440665.5, ISNI 0000 0004 1757 641X, Changchun University of Traditional Chinese Medicine, ; Changchun, 130012 China
                [2 ]GRID grid.464402.0, ISNI 0000 0000 9459 9325, College of Traditional Chinese Medicine, , Shandong University of Traditional Chinese Medicine, ; Jinan, 250000 China
                [3 ]The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, ( https://ror.org/052q26725) Jinan, 250000 China
                [4 ]Experimental Center, Shandong University of Traditional Chinese Medicine, ( https://ror.org/0523y5c19) Jinan, 250000 China
                [5 ]The First Affiliated Hospital of Changchun University of Chinese Medicine, ( https://ror.org/035cyhw15) Changchun, 130012 China
                [6 ]GRID grid.464297.a, Department of Endocrinology, , Guang’anmen Hospital, China Academy of Chinese Medical Sciences, ; Beijing, China
                Author information
                http://orcid.org/0000-0002-6249-2237
                Article
                744
                10.1186/s10020-023-00744-0
                10604535
                37884902
                03017428-df0a-49c1-a346-3c73bcc5af3a
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 10 January 2023
                : 18 October 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100014718, Innovative Research Group Project of the National Natural Science Foundation of China;
                Award ID: 81800740
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100007129, Natural Science Foundation of Shandong Province;
                Award ID: ZR2020MH361
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100010031, Postdoctoral Research Foundation of China;
                Award ID: 2021M692750
                Award Recipient :
                Funded by: Shandong Medical & Health Science and Technology Development Foundation
                Award ID: 2019WS562
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100020196, Shandong Provincial Postdoctoral Science Foundation;
                Award ID: ZR2023MH300
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Feinstein Institute for Medical Research 2023

                epithelial-to-mesenchymal transition,diabetic kidney disease,ctrc2,creb,smad2/3

                Comments

                Comment on this article